ADAMTS13 (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "ADAMTS13" in Galician language version.

refsWebsite

Global rank Galician rank

7nih.gov

4^th place

6^th place

7doi.org

2^nd place

7^th place

1web.archive.org

1^st place

1hematologylibrary.org

low place

2,448^th place

1asnjournals.org

low place

asnjournals.org

jasn.asnjournals.org

Tsai HM (April 2003). "Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura". Journal of the American Society of Nephrology 14 (4): 1072–81. PMID 12660343. doi:10.1097/01.ASN.0000060805.04118.4C.

doi.org

dx.doi.org

Levy GG, Motto DG, Ginsburg D (July 2005). "ADAMTS13 turns 3". Blood 106 (1): 11–7. PMID 15774620. doi:10.1182/blood-2004-10-4097. Arquivado dende o orixinal o 24-08-2010. Consultado o 09-09-2018.
Tsai HM (April 2003). "Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura". Journal of the American Society of Nephrology 14 (4): 1072–81. PMID 12660343. doi:10.1097/01.ASN.0000060805.04118.4C.
Furlan M, Lämmle B (June 2001). "Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease". Best Practice & Research. Clinical Haematology 14 (2): 437–54. PMID 11686108. doi:10.1053/beha.2001.0142.
Sonneveld MA, de Maat MP, Leebeek FW (July 2014). "Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis". Blood Reviews 28 (4): 167–78. PMID 24825749. doi:10.1016/j.blre.2014.04.003.
Maino A, Siegerink B, Lotta LA, Crawley JT, le Cessie S, Leebeek FW, Lane DA, Lowe GD, Peyvandi F, Rosendaal FR (August 2015). "Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis". Journal of Thrombosis and Haemostasis 13 (8): 1396–404. PMID 26073931. doi:10.1111/jth.13032.
Sonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL, Rottensteiner H, Scheiflinger F, Koudstaal PJ, Ikram MA, Leebeek FW (December 2015). "Low ADAMTS13 activity is associated with an increased risk of ischemic stroke". Blood 126 (25): 2739–46. PMID 26511134. doi:10.1182/blood-2015-05-643338.
Denorme F, Kraft P, Pareyn I, Drechsler C, Deckmyn H, Vanhoorelbeke K, Kleinschnitz C, De Meyer SF (2017). "Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease". PLOS One 12 (6): e0179258. PMC 5462472. PMID 28591212. doi:10.1371/journal.pone.0179258.

hematologylibrary.org

bloodjournal.hematologylibrary.org

Levy GG, Motto DG, Ginsburg D (July 2005). "ADAMTS13 turns 3". Blood 106 (1): 11–7. PMID 15774620. doi:10.1182/blood-2004-10-4097. Arquivado dende o orixinal o 24-08-2010. Consultado o 09-09-2018.

nih.gov

ncbi.nlm.nih.gov

Levy GG, Motto DG, Ginsburg D (July 2005). "ADAMTS13 turns 3". Blood 106 (1): 11–7. PMID 15774620. doi:10.1182/blood-2004-10-4097. Arquivado dende o orixinal o 24-08-2010. Consultado o 09-09-2018.
Tsai HM (April 2003). "Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura". Journal of the American Society of Nephrology 14 (4): 1072–81. PMID 12660343. doi:10.1097/01.ASN.0000060805.04118.4C.
Furlan M, Lämmle B (June 2001). "Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease". Best Practice & Research. Clinical Haematology 14 (2): 437–54. PMID 11686108. doi:10.1053/beha.2001.0142.
Sonneveld MA, de Maat MP, Leebeek FW (July 2014). "Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis". Blood Reviews 28 (4): 167–78. PMID 24825749. doi:10.1016/j.blre.2014.04.003.
Maino A, Siegerink B, Lotta LA, Crawley JT, le Cessie S, Leebeek FW, Lane DA, Lowe GD, Peyvandi F, Rosendaal FR (August 2015). "Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis". Journal of Thrombosis and Haemostasis 13 (8): 1396–404. PMID 26073931. doi:10.1111/jth.13032.
Sonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL, Rottensteiner H, Scheiflinger F, Koudstaal PJ, Ikram MA, Leebeek FW (December 2015). "Low ADAMTS13 activity is associated with an increased risk of ischemic stroke". Blood 126 (25): 2739–46. PMID 26511134. doi:10.1182/blood-2015-05-643338.
Denorme F, Kraft P, Pareyn I, Drechsler C, Deckmyn H, Vanhoorelbeke K, Kleinschnitz C, De Meyer SF (2017). "Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease". PLOS One 12 (6): e0179258. PMC 5462472. PMID 28591212. doi:10.1371/journal.pone.0179258.

web.archive.org

Levy GG, Motto DG, Ginsburg D (July 2005). "ADAMTS13 turns 3". Blood 106 (1): 11–7. PMID 15774620. doi:10.1182/blood-2004-10-4097. Arquivado dende o orixinal o 24-08-2010. Consultado o 09-09-2018.